Search for: "Novartis Corporation " Results 121 - 140 of 311
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
27 Sep 2010, 12:59 am by FDABlog HPM
Karst –    Just two days after Novartis Pharmaceuticals Corporation (“Novartis”) filed a Complaint in the U.S. [read post]
3 May 2013, 6:33 pm by Swaraj Paul Barooah
One can hope that (while certainly corporations are people too), this '... for the people' government is trying to sort out their own (non-corporation) people's medical problems with the same vigour, for, at last check, they were still having plenty of issues with medical bills. [read post]
16 Dec 2011, 9:15 pm by Patent Docs
Conference highlights include: • Benefit from industry perspectives throughout the day with IBC faculty of experienced corporate counsel; • Hear the tips and traps of current tactics for maximising patent life cycles and data exclusivity; • Gain an excellent understanding of the latest SPC position including a consideration of the judgments of key decisions including Novartis v Actavis, Medeva and Georgetown University; • Analyse the practical implications on… [read post]
5 Dec 2011, 1:20 pm
A strong answer to every IT infrastructure manager's prayers, cloud computing can provide both a scalable on-demand combination of hardware, software and services, as well as helping fulfill corporate/social mandates for becoming greener. [read post]
12 Mar 2024, 12:46 pm by admin
Wyeth-Ayerst Laboratories Co., 278 F.Supp.2d 684, 700 (W.D.N.C. 2003) (expert witnesses may not opine about corporate intent and motive) (barring Dr. [read post]
6 Dec 2013, 3:14 pm
Switzerland also has a long history of social equality, and many citizens were offended by cases like that of Daniel Vasella, the former chief executive of the pharmaceutical company Novartis, who this year demanded a $78 million severance package in return for a promise not to share his know-how with any competitors. [read post]
25 Nov 2011, 5:00 am by Bexis
Novartis Pharmaceuticals Corp., 2011 WL 5835414, slip op. [read post]
9 Feb 2013, 4:04 pm by Larry Catá Backer
  All of this is inconsistent with traditional notions of the role of law, the scope of corporate governance and the nature of corporate social responsibility int he United States. [read post]
30 Dec 2012, 3:30 am by Gene Quinn & Angel Krippner
On October 31, 2012, Acacia Research Corporation (Nasdaq:ACTG) announced that its subsidiaries... [read post]
29 Jan 2016, 3:58 am by SHG
Now that was a crime worthy of redress, but it’s hard to blame Novartis for doing what was in its corporate interests. [read post]
20 Mar 2012, 7:55 am
On 3 August 2004 Novartis AG lodged a notice of opposition in respect of the goods listed above. [read post]
24 Jan 2012, 6:34 pm by FDABlog HPM
District Court for the Northern District of Illinois (Eastern Division), the court denied Plaintiffs’ Seattle Children’s Hospital, Novartis Vaccines and Diagnostics, Inc., and Novartis Pharmaceuticals Corporation (collectively “Novartis”) Motion to Dismiss the lawsuit that they brought against Akorn, Inc. [read post]
4 Nov 2011, 4:09 am by John Hopkins
Novartis Pharmaceutical paid $422.5 million to settle claims it promoted its epilepsy drug, Trileptal, for off label uses. [read post]
6 Sep 2023, 5:58 am by Bob Ambrogi
With the goal of simplifying and standardizing those business dealings, the non-profit organization oneNDA developed an open-source NDA that, since its launch in 2021, has been adopted by more than 1,000 companies, including American Express, Google, Novartis and Panasonic. [read post]
17 Jul 2020, 8:57 am
Pix Credit HEREWorking Group on the issue of human rights and transnational corporations and other business enterprises Please join two virtual events to launch the Working Group’s latest report to the Human Rights Council -  Connecting the business and human rights and the anti-corruption agendas Following the presentation of its report, the Working Group is convening two discussions on the links between anti-corruption efforts… [read post]
17 Feb 2011, 1:59 pm by AALRR
  SmithKline Beecham Corporation (“Glaxo”) hired plaintiffs in 2003 to meet with physicians and encourage them to prescribe Glaxo pharmaceuticals. [read post]
9 Jan 2012, 4:00 am by Steve McConnell
Novartis Pharmaceuticals Corporation, Case No. 2:08-CV-02088 (W.D. [read post]
29 May 2009, 4:49 am
Most recently, a Montgomery Alabama jury returned a $78 million dollar judgment against the drug manufacturer Sandoz, a subsidiary of Novartis. [read post]